---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-082077"
form_type: "8-K"
ticker: "ORIC"
cik: "0001796280"
company_name: "Oric Pharmaceuticals, Inc."
filed_at: "2024-03-29T23:59:59+00:00"
generated_at: "2026-06-04T05:30:11.668085+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ORIC Pharma boosts inducement equity plan by 650k shares to 1.15M total

## Summary
- Compensation Committee approved amended 2022 Inducement Plan, adding 650,000 shares.
- Total shares reserved under plan now 1,150,000, for equity grants to new employees.
- Plan adopted without stockholder approval per Nasdaq inducement award rules.
- Awards may only go to individuals not previously employees/directors, as hiring inducement.
- Effective March 26, 2024; plan terms substantially similar to 2020 Equity Incentive Plan.

## SEC filing metadata
- accession: 0001193125-24-082077
- form_type: 8-K
- ticker: ORIC
- cik: 0001796280
- company_name: Oric Pharmaceuticals, Inc.
- filed_at: 2024-03-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1796280/000119312524082077/0001193125-24-082077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1796280/000119312524082077/d802175d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-082077
- JSON: https://secwatch.observer/filing/0001193125-24-082077.json
- Plain text: https://secwatch.observer/filing/0001193125-24-082077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.